- Phase II study of nedaplatin and irinotecan as adjuvant chemotherapy for completely resected non-small cell lung cancer
Shuji Murakami et al, 2018, Cancer Chemotherapy and Pharmacology CrossRef - Analyzing the clinical actionability of germline pharmacogenomic findings in oncology
Rebecca Wellmann et al, 2018, Cancer CrossRef - UGT1A1 polymorphisms with irinotecan-induced toxicities and treatment outcome in Asians with Lung Cancer: a meta-analysis
Xuewei Chen et al, 2017, Cancer Chemotherapy and Pharmacology CrossRef - UGT1A1 Gene Polymorphisms in Patients with Small Cell Lung Cancer Treated with Irinotecan-Platinum Doublet Chemotherapy and Their Association with Gastrointestinal Toxicity and Overall Survival
Ankan Bandyopadhyay et al, 2021, The Oncologist CrossRef